US Stock MarketDetailed Quotes

DRUGS MADE IN AMER ACQUISITION CORP UNIT EXP 15/10/2029 (1 ORD SHS & 1 RT) (DMAAU)

Watchlist
  • 10.580
  • 0.0000.00%
Close May 1 16:00 ET
354.62MMarket Cap0.00P/E (TTM)

DRUGS MADE IN AMER ACQUISITION CORP UNIT EXP 15/10/2029 (1 ORD SHS & 1 RT) (DMAAU) Income Statement

Quarterly+Annual
YOY yoy
Hide blank lines yoy
(FY)Dec 31, 2025
(Q4)Dec 31, 2025
(Q3)Sep 30, 2025
(Q2)Jun 30, 2025
(Q1)Mar 31, 2025
(Q3)Sep 30, 2024
Total revenue
0
0
0
0
0
0
Operating revenue
--0
--0
--0
--0
--0
--0
Cost of revenue
Gross profit
Operating expense
2.82M
2.09M
81.95%263.7K
131.92K
330.93K
144.93K
Selling and administrative expenses
--2.82M
--2.09M
81.95%263.7K
--131.92K
--330.93K
--144.93K
-General and administrative expense
--2.82M
--2.09M
81.95%263.7K
--131.92K
--330.93K
--144.93K
Operating profit
-2.82M
-2.09M
-81.95%-263.7K
-131.92K
-330.93K
-144.93K
Net non-operating interest income expense
8.76M
2.3M
2.45M
2.42M
1.59M
0
Non-operating interest income
--8.76M
--2.3M
--2.45M
--2.42M
--1.59M
--0
Other net income (expense)
Income before tax
5.94M
212.96K
1,607.34%2.18M
2.29M
1.25M
-144.93K
Income tax
Net income
5.94M
212.96K
1,607.34%2.18M
2.29M
1.25M
-144.93K
Net income continuous Operations
--5.94M
--212.96K
1,607.34%2.18M
--2.29M
--1.25M
---144.93K
Minority interest income
Net income attributable to the parent company
5.94M
212.96K
1,607.34%2.18M
2.29M
1.25M
-144.93K
Preferred stock dividends
Other preferred stock dividends
Net income attributable to common stockholders
5.94M
212.96K
1,607.34%2.18M
2.29M
1.25M
-144.93K
Basic earnings per share
Diluted earnings per share
Dividend per share
Currency Unit
USD
USD
USD
USD
USD
USD
Audit Opinions
Unqualified Opinion with Explanatory Notes
--
--
--
--
--
(FY)Dec 31, 2025(Q4)Dec 31, 2025(Q3)Sep 30, 2025(Q2)Jun 30, 2025(Q1)Mar 31, 2025(Q3)Sep 30, 2024
Total revenue 000000
Operating revenue --0--0--0--0--0--0
Cost of revenue
Gross profit
Operating expense 2.82M2.09M81.95%263.7K131.92K330.93K144.93K
Selling and administrative expenses --2.82M--2.09M81.95%263.7K--131.92K--330.93K--144.93K
-General and administrative expense --2.82M--2.09M81.95%263.7K--131.92K--330.93K--144.93K
Operating profit -2.82M-2.09M-81.95%-263.7K-131.92K-330.93K-144.93K
Net non-operating interest income expense 8.76M2.3M2.45M2.42M1.59M0
Non-operating interest income --8.76M--2.3M--2.45M--2.42M--1.59M--0
Other net income (expense)
Income before tax 5.94M212.96K1,607.34%2.18M2.29M1.25M-144.93K
Income tax
Net income 5.94M212.96K1,607.34%2.18M2.29M1.25M-144.93K
Net income continuous Operations --5.94M--212.96K1,607.34%2.18M--2.29M--1.25M---144.93K
Minority interest income
Net income attributable to the parent company 5.94M212.96K1,607.34%2.18M2.29M1.25M-144.93K
Preferred stock dividends
Other preferred stock dividends
Net income attributable to common stockholders 5.94M212.96K1,607.34%2.18M2.29M1.25M-144.93K
Basic earnings per share
Diluted earnings per share
Dividend per share
Currency Unit USDUSDUSDUSDUSDUSD
Audit Opinions Unqualified Opinion with Explanatory Notes----------
Market Insights
China Concept Stocks
View More
Middle East conflict spreads to the stock market! How should investors respond?
According to Axios, on Sunday local time, Trump rejected Iran's latest ceasefire proposal, prompting a sharp response from Iran: no one woul Show More